The company offers herbal-based products including Go Deep (a deep penetrating healing salve), Go Deep EXTRA (for pain relief), Face Garden (antioxidant and moisturizing cream), Body Garden (moisturizing body lotion), and Lip Garden (emollient balm). Recent strategic moves include expanding the PrestoDoctor telemedicine service to Illinois, launching cannabis lozenges in California, and acquiring PrestoDoctor for $9M to enhance telemedicine offerings.
Cyborg Score Rationale
As of May 2025, the company had annual revenue of $3.8M and approximately 12 employees. The company operates with limited scale and financial resources on the OTCQB market, facing structural challenges common to micro-cap cannabis operations.
Top Insights
Cannabis Sativa, Inc. was incorporated under Nevada law in November 2005, formerly named Ultra Sun Corporation.
As of May 2025, the company reported annual revenue of $3.8M with approximately 12 employees across 4 continents.
The company has been awarded a U.S. patent for Ecuadorian Sativa cannabis strain and has patents pending on cannabis-based compositions for treating hypertension and lozenge delivery systems.
As of April 2023, Cannabis Sativa, Inc. had no permanent employees and operated out of virtual offices maintained by officers, directors, and contractors.
Named Competitors
One World Pharma — Cannabis and hemp product distributor
Landrace Bioscience — Cannabis genetics and cultivation
CanaFarma — Cannabis product manufacturer and distributor
Recent Developments
(May 2025) Annual revenue reached $3.8M with ~12 employees across 4 continents
(2022) Expanded PrestoDoctor telemedicine service and launched cannabis lozenges in California
Acquisition of PrestoDoctor for $9M to strengthen telemedicine market position
Open the full interactive Cannabis Sativa, Inc. report
Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.